Form 8-K Mirati Therapeutics, For: Sep 20 Sep 20, 2021 08:11AM

Exhibit 99.1

 

Mirati Therapeutics Appoints David Meek as Chief Executive Officer

Charles M. Baum, M.D., Ph.D to Continue in New Role of President, Founder and Head of Research and Development

SAN DIEGO – September 20, 2021 – Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today announced the appointment of David Meek as Chief Executive Officer (CEO), effective immediately. Mr. Meek will also join the Company’s Board... (continue reading...)


Form D BC Partners Electron Sep 20, 2021 08:09AM .FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align: right; } .SmallFormData { color: blue; background-color: white; font-size: 10px; font-family: Times, serif; } .FootnoteData { color:... (continue reading...)
Form 8-K Phathom Pharmaceuticals, For: Sep 17 Sep 20, 2021 08:07AM 8-K false 0001783183 0001783183 2021-09-17 2021-09-17

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): September 17, 2021

 

 

PHATHOM PHARMACEUTICALS, INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-39094   ... (continue reading...)
Form DEFA14A GigCapital4, Inc. Sep 20, 2021 08:06AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

 

SCHEDULE 14A

(RULE 14a-101)

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

 

 

Filed by the Registrant  ☒                             Filed by a Party other than the Registrant  ☐

Check the appropriate box:

 

☐   Preliminary Proxy Statement ☐   Confidential, for Use of the Commission Only (as permitted by Rule... (continue reading...)
Form 6-K Eros STX Global Corp For: Sep 20 Sep 20, 2021 08:06AM

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Section 13(a)-16 or 15(d)-16

of the Securities Exchange Act of 1934

For the month of September, 2021

001-36176

(Commission file number)

 

 

EROS STX GLOBAL CORPORATION

(Exact name of registrant as specified in its charter)

 

 

3900 West Alameda Avenue, 32nd Floor

Burbank, California 91505

Tel: (818) 524-7000

... (continue reading...)


More SEC Filings

View Older Stories

Sep 20, 2021 08:05AM Form SC 13D/A APi Group Corp Filed by: FRANKLIN MARTIN E
Sep 20, 2021 08:03AM Form 8-K PEDEVCO CORP For: Sep 20
Sep 20, 2021 08:03AM Form 8-K Benitec Biopharma Inc. For: Sep 20
Sep 20, 2021 08:03AM Form 8-K SYNLOGIC, INC. For: Sep 20
Sep 20, 2021 08:03AM Form 6-K Ambow Education Holding For: Jun 30
Sep 20, 2021 08:01AM Form 10-K Benitec Biopharma Inc. For: Jun 30
Sep 20, 2021 08:01AM Form 8-K MIDDLEFIELD BANC CORP For: Sep 20
Sep 20, 2021 08:01AM Form SC 13D/A RING ENERGY, INC. Filed by: KUKES SIMON G
Sep 20, 2021 08:01AM Form DEFA14A GigCapital4, Inc.
Sep 20, 2021 08:01AM Form 4 J.Jill, Inc. For: Sep 17 Filed by: Spofford Claire
Sep 20, 2021 08:00AM Form 8-K SELECTA BIOSCIENCES INC For: Sep 20
Sep 20, 2021 08:00AM Form 4 Summit Midstream Partner For: Sep 16 Filed by: Deneke J Heath
Sep 20, 2021 08:00AM Form 6-K Cognyte Software Ltd. For: Jul 31
Sep 20, 2021 07:59AM Form 6-K PLDT Inc. For: Sep 20
Sep 20, 2021 07:54AM Form 8-K TRAQIQ, INC. For: Sep 17
Sep 20, 2021 07:48AM Form 6-K Medigus Ltd. For: Jun 30
Sep 20, 2021 07:45AM Form 8-K Teladoc Health, Inc. For: Sep 17
Sep 20, 2021 07:42AM Form 425 Athena Technology Acquis Filed by: Athena Technology Acquisition Corp.
Sep 20, 2021 07:37AM Form 1-U True Leaf Brands Inc. For: Sep 20
Sep 20, 2021 07:34AM Form D/A RF Parent, Inc.
Sep 20, 2021 07:31AM Form 25 WASHINGTON PRIME GROUP
Sep 20, 2021 07:31AM Form 25 WASHINGTON PRIME GROUP
Sep 20, 2021 07:30AM Form 25 WASHINGTON PRIME GROUP
Sep 20, 2021 07:21AM Form 425 Live Oak Acquisition Filed by: Live Oak Acquisition Corp II
Sep 20, 2021 07:20AM Form 425 Cartesian Growth Corp Filed by: Cartesian Growth Corp
Sep 20, 2021 07:17AM Form 8-K Cartesian Growth Corp For: Sep 20
Sep 20, 2021 07:16AM Form 8-K Live Oak Acquisition For: Sep 20
Sep 20, 2021 07:15AM Form 8-K Weatherford Internationa For: Sep 20
Sep 20, 2021 07:14AM Form 20-F/A Gol Intelligent Airlines For: Dec 31
Sep 20, 2021 07:12AM Form D Spring Valley Prospect
Sep 20, 2021 07:12AM Form 8-K COMPASS MINERALS INTERNA For: Sep 20
Sep 20, 2021 07:07AM Form 20FR12B Getnet Adquirencia E
Sep 20, 2021 07:07AM Form 8-K Target Hospitality Corp. For: Sep 20
Sep 20, 2021 07:06AM Form 8-K BIOCRYST PHARMACEUTICALS For: Sep 15
Sep 20, 2021 07:05AM Form 8-K Matinas BioPharma Holdin For: Sep 17
Sep 20, 2021 07:03AM Form 8-K Anterix Inc. For: Sep 20
Sep 20, 2021 07:03AM Form DEFA14A Astrea Acquisition Corp.
Sep 20, 2021 07:02AM Form 8-K WINDTREE THERAPEUTICS For: Sep 20
Sep 20, 2021 07:01AM Form 425 Trident Acquisitions Filed by: Trident Acquisitions Corp.
Sep 20, 2021 07:01AM Form 3 OOMA INC For: Sep 07 Filed by: Hamamatsu Shigeyuki
Sep 20, 2021 07:01AM Form 8-K Astrea Acquisition Corp. For: Sep 17
Sep 20, 2021 07:01AM Form DEF 14C NEWTOWN LANE MARKETING For: Sep 20
Sep 20, 2021 07:01AM Form 8-K ORASURE TECHNOLOGIES For: Sep 14
Sep 20, 2021 07:01AM Form 425 Trident Acquisitions Filed by: Trident Acquisitions Corp.
Sep 20, 2021 06:59AM Form 6-K NOVO NORDISK A S For: Sep 20
Sep 20, 2021 06:59AM Form 425 Great Western Bancorp, Filed by: Great Western Bancorp, Inc.
Sep 20, 2021 06:58AM Form 8-K Great Western Bancorp, For: Sep 15
Sep 20, 2021 06:57AM Form 6-K BioNTech SE For: Sep 20
Sep 20, 2021 06:56AM Form 4 Hyatt Hotels Corp For: Sep 16 Filed by: VONDRASEK MARK R
Sep 20, 2021 06:56AM Form 8-K CareMax, Inc. For: Sep 20
View Older Stories